Naloxegol Drug Utilization PASS

Trial Identifier:	D3820R00006
Sponsor:	AstraZeneca
NCTID::	NCT02813148
Start Date:	July 2016
Primary Completion Date:	December 2018
Study Completion Date:	December 2018
Condition:	Digestive & Intestinal - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Finland	Espoo, Finland
Germany	Frankfurt am Main, Germany
United Kingdom	Surrey, United Kingdom

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.